Results 151 to 160 of about 2,933 (228)
2024 Update of Chinese Guidelines for Diagnosis and Treatment of Hyperuricemia and Gout Part I: Recommendations for General Patients. [PDF]
Sun M +30 more
europepmc +1 more source
Evaluation of Probenecid Against Filovirus Replication in Vero E6 Cells. [PDF]
Alfson K +4 more
europepmc +1 more source
Risk of urolithiasis associated with allopurinol versus benzbromarone among patients with gout: a population-based cohort study. [PDF]
Kang EH +6 more
europepmc +1 more source
[Uricosuric agents: Should they be used in asymptomatic hyperuricemia?].
openaire +1 more source
Uricosuric Agents and Phenolsulfonphthalein Excretion
Introduction At the time of his historic discovery of hyperuricemia in gout, A. B. Garrod stated that "Gout would thus appear, at least partly, to depend on a loss of power (temporary or permanent) in the uric acid-excreting function of the kidneys."1Thus began a century of interest and controversy over the role of the kidney in the pathogenesis of ...
D S, NEWCOMBE, A S, COHEN
+5 more sources
Zoxazolamine — A Potent Uricosuric Agent
ZOXAZOLAMINE¶ has been widely used during the past two years for the purpose of decreasing spasm of skeletal muscle, presumably via a depressant effect upon polysynaptic pathways in the central nervous system. Occasional side effects, such as drowsiness, lightheadedness, dizziness, abdominal discomfort, vomiting, headache and transient blotching of the
E B, Reed, T V, Feichtmeir, F M, Willett
openaire +3 more sources
Uricosuric Action of Cholecystographic Agents
Abstract The oral cholecystographic agents are highly lipid-soluble carboxylic acids. In this respect they resemble probenecid and some other uricosuric agents. Because of continuing case reports of nephrotoxicity of the gallbladder dyes, the possibility was raised that they have a uricosuric action. Ratios of uric acid to creatinine were determined in
Gilbert H. Mudge
openaire +3 more sources
USE OF THE NEWER URICOSURIC AGENTS IN THE MANAGEMENT OF GOUT
Zoxazolamine in doses up to 125 mg., administered to patients with gout, increased the urinary excretion of uric acid and lowered the serum urate level. In some patients increasing the dosage to 250 mg. intensified these effects to the point of causing a urate crystalluria.
J E, SEEGMILLER, A I, GRAYZEL
openaire +3 more sources

